This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
X-linked Lymphoproliferative Disorders
Information about X-linked Lymphoproliferative Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of X-linked Lymphoproliferative Disorders
Most recent studies have shown that X-linked Lymphoproliferative Disorders shares some biological mechanisms with agammaglobulinemia, anemia, aplastic-anemia, burkitt-lymphoma, common-variable-immunodeficiency, epstein-barr-virus-infections, herpesviridae-infections, hypogammaglobulinemia, immunologic-deficiency-syndromes, infectious-mononucleosis, infective-disorder, lymphohistiocytosis-hemophagocytic, lymphoma, lymphoproliferative-disorders, malignant-paraganglionic-neoplasm, neoplasms, primary-immune-deficiency-disorder, virus-diseases.
Among the many pathways, these few ones have gauged particular interests from scientists studying X-linked Lymphoproliferative Disorders, and have been seen in publications frequently: B Cell Activation, B Cell Proliferation, Cell Activation, Cell Death, Cell Development, Cell Differentiation, Cell Proliferation, Cytokine Production, Cytokine Secretion, Cytolysis, Dna Methylation, Germinal Center Formation, Immune Response, Lymphocyte Activation, Lymphocyte Proliferation, Pathogenesis, Secretion, T Cell Activation, T Cell Proliferation, Tropism
Quite a number of genes have been found to play important roles in X-linked Lymphoproliferative Disorders, such as APCS, CD244, CD48, CD84, CD8A, CTLA4, FYN, HLA-DQA1, IFNG, IL2, LY9, NOD2, SH2D1A, SH2D1B, SLAMF1, SLAMF6, SRC, XIAP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.